A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope proteinby Qu et al.
Results showed in this article have strong implications for developing anti-ZIKV vaccines and therapeutic mAbs.
4th February 2020 • comment
Viral emergence and immune interplay in flavivirus vaccinesby Fischer et al.
1st January 2020 • comment
Yeast-produced subunit protein vaccine elicits broadly neutralizing antibodies that protect mice against Zika virus lethal infectionby Zhang et al.
Yeast-derived EDIII is a safe and effective ZIKV vaccine candidate with desirable production traits.
1st October 2019 • comment
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in miceby Kum et al.
The authors of this study report the engineering of a chimeric virus vaccine candidate (YF-ZIKprM/E) by replacing the antigenic surface glycoproteins and the capsid anchor of YFV-17D with those of a prototypic Asian lineage ZIKV isolate.
13th December 2018 • comment
4 EU-funded Zika consortia met in Marseille during the International Symposium to discuss a common strategy for vaccine developmentby ZIKAlliance
14th June 2018 • comment